Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 4NIH 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 11Head & Neck 5Gastrointestinal 5CNS 4Sarcoma 3Other solid neoplasm 3Gynecologic 3Genitourinary 2Endocrine 2Dermatologic 2Breast 2

Conditions

Unspecified Childhood Solid Tumor, Protocol Specific 1Unspecified Adult Solid Tumor, Protocol Specific 1Solitary Fibrous Tumor, Pleural 1Mesothelioma, Malignant 1

Interventions

Cisplatin 28Irinotecan 18Gemcitabine 18Paclitaxel 14alvocidib 13Fluorouracil 11Oxaliplatin 10Cyclophosphamide 10Carboplatin 10Leucovorin 8Bortezomib 8Biopsy 8Taxes 7Radiotherapy 7Pemetrexed 7Magnetic Resonance Spectroscopy 7Doxorubicin 73-aminopyridine-2-carboxaldehyde thiosemicarbazone 7Specimen Handling 6tanespimycin 5Vorinostat 5LMB-100 5Early Intervention, Educational 5Bevacizumab 5temsirolimus 4sargramostim 4Sorafenib 4Sirolimus 4Platinum 4Decitabine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Gefitinib × Other solid neoplasm × Clear all
NCT00039390 2013-01-25

Gefitinib and Capecitabine in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
41 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00040781 2013-01-23

Gefitinib in Treating Children With Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
45 enrolled
Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

NCT00025207 2013-01-17

Gefitinib in Treating Patients With Malignant Mesothelioma

National Cancer Institute (NCI)

Phase 2 Completed
40 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

Data powered by HemOnc (CC BY 4.0) Colophon âš¡